ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Access to care"

  • Abstract Number: 0227 • ACR Convergence 2022

    The Rheumatology Workforce: Analyzing Geographic and Temporal Variations Among the Rheumatology Physician Workforce in the United States

    Kavish Singh1, Lynn Foster-Johnson2, Sladjana Skopelja-Gardner3, Arabi Rasendrakumar4, Temitope Ajayi5 and Aakanksha Khanna6, 1Montefiore Medical Center, Brooklyn, NY, 2Dartmouth Geisel School of Medicine, Lebanon, NH, 3Dartmouth Hitchcock Medical Center, Lebanon, NH, 4University of Buffalo, Buffalo, NY, 5University at Buffalo, Buffalo, NY, 6Dartmouth-Hitchcock Medical Center, Lebanon, NH

    Background/Purpose: To analyze recent trends in the rheumatology workforce related to temporal and national geographic variation in the United States (US). Methods: The publicly available physician workforce…
  • Abstract Number: 1101 • ACR Convergence 2022

    Sex and Racial Differences in Systemic Lupus Erythematosus Among U.S. Adults in the All of Us Research Program

    Rachel Elam1, Deepak Ayyala1, Adria Madera-Acosta1, Stephen Bell1, Anam Qureshi1, Christopher Rice2, Laura Carbone1, Steven Coughlin1 and Hong Shi3, 1Augusta University, Augusta, GA, 2Moses H. Cone Memorial Hospital, Augusta, GA, 3Department of Internal Medicine/Division of Rheumatology, Vascular Biology Center, Augusta, GA

    Background/Purpose: Most persons with systemic lupus erythematosus (SLE) are women, and men with SLE are an understudied demographic. The purpose of this study was to…
  • Abstract Number: 1530 • ACR Convergence 2022

    Scleroderma Renal Crisis: Time to Initiation of Therapy Does Not Affect Mortality

    Aditi Patel1, Chao Zhang1 and Soumya Chatterjee2, 1Cleveland Clinic, Cleveland, OH, 2Cleveland Clinic, Richmond Heights, OH

    Background/Purpose: Scleroderma renal crisis (SRC) is a rare complication in patients with systemic sclerosis (SSc), characterized by accelerated hypertension and acute kidney injury. ACE inhibitors…
  • Abstract Number: 0081 • ACR Convergence 2022

    Impact of the COVID-19 Pandemic on Rheumatology Services in a Universal Healthcare Setting in Canada: A Population-based Study

    Timothy Kwok1, Bindee Kuriya1, Lauren King1, Lihi Eder2, Carter Thorne3, Zhiyin Li4, therese stukel4, longdi fu4, alexander Kopp4 and Jessica Widdifield5, 1University of Toronto, Toronto, ON, Canada, 2Women’s College Research Institute, Department of Medicine, University of Toronto, Toronto, ON, Canada, 3Southlake Regional Health Centre, Newmarket, ON, Canada, 4ICES, Toronto, ON, Canada, 5Sunnybrook Research Institute, Toronto, ON, Canada

    Background/Purpose: We sought to describe changes in service delivery and access to rheumatologists in terms of changes in weekly total office visit volumes, telemedicine visits,…
  • Abstract Number: 0240 • ACR Convergence 2022

    Few and Far Between: Addressing the Pediatric Rheumatology Workforce Gap with a Spotlight on Medicine-pediatrics Residency Trained Rheumatologist Career Paths

    Kimberly DeQuattro1, Cuoghi Edens2, Connie Herndon3, Bethany Marston4 and Beth Jonas5, 1University of Pennsylvania, Philadelphia, PA, 2University of Chicago, Chicago, IL, 3American College of Rheumatology, Atlanta, GA, 4University of Rochester, Rochester, NY, 5University of North Carolina Chapel Hill, Chapel Hill, NC

    Background/Purpose: The pediatric rheumatology workforce faces a critical shortage. The recent ACR Pediatric Rheumatology Workforce Study projects that by 2030, modest expansion of the 300…
  • Abstract Number: 1224 • ACR Convergence 2022

    ‘No Route Map’: The Complex Healthcare Journeys of People with Fibromyalgia – a Record Linkage Study in the UK

    Rosemary Hollick, Ka-Kin Lam, Marcus Beasley, Gareth Jones, Corri Black and Gary Macfarlane, University of Aberdeen, Aberdeen, Scotland, United Kingdom

    Background/Purpose: Healthcare services for persons with fibromyalgia (FM) lack co-ordination. Patients describe feeling 'invisible' within healthcare systems and often report poor experiences of care, particularly…
  • Abstract Number: 1583 • ACR Convergence 2022

    Race and Disease Severity Predict Reduced Response to Treat-to-Target Urate Lowering Therapy in Gout: Post-hoc Analysis of a Multicenter, Randomized, Double-Blind, Non-Inferiority Trial

    Lindsay Helget1, James O'Dell1, Jeff Newcomb1, Maria Androsenko2, Mary Brophy2, Anne Davis-Karim3, Bryant England1, Ryan Ferguson2, Michael Pillinger4, Tuhina Neogi5, Paul Palevsky6, Hongsheng Wu2 and Ted Mikuls7, 1University of Nebraska Medical Center, Omaha, NE, 2VA Boston Cooperative Studies Program Coordinating Center, Boston, MA, 3VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Albuquerque, NM, 4NYU Grossman School of Medicine, New York, NY, 5Boston University School of Medicine, Boston, MA, 6University of Pittsburgh School of Medicine, Pittsburgh, Pittsburgh, 7Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: The ACR recommends a treat-to-target strategy in the management of gout, involving titration of urate lowering therapy (ULT) to a serum urate (SU) goal…
  • Abstract Number: 0086 • ACR Convergence 2022

    Patient and Provider Perspectives on Barriers to Communication and Care of Latinx Patients with Lupus and Rheumatoid Arthritis

    Monica Crespo Bosque1, Pablo Weilg Espejo2 and Candace Feldman3, 1Boston University, Boston, MA, 2Boston Medical Center, Chelsea, MA, 3Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Latinx patients, a heterogenous population with a range of experiences including migration, language, and race, experience a disproportionate burden of adverse outcomes from systemic…
  • Abstract Number: 0382 • ACR Convergence 2022

    Factors Associated with Diagnostic Delay in Axial Spondyloarthritis: Impact of Clinical Factors and Social Vulnerability

    Gregory McDermott1, Faith Selzer1, Sizheng Zhao2, Joerg Ermann3 and Jeffrey Katz1, 1Brigham and Women's Hospital, Boston, MA, 2University of Manchester, Liverpool, United Kingdom, 3Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Patients with axial spondyloarthritis (axSpA) experience significant delay between symptom onset and diagnosis. Determinants of delay are incompletely understood. We investigated the associations between…
  • Abstract Number: 1285 • ACR Convergence 2022

    Joint Injection Workflow in Rheumatology – an Opportunity to Improve Efficiency and Physician Satisfaction

    Melissa Band1, Eric Newman2, Andrea Berger1, Kirsten Koons3, Madhuri Duggirala1, Rajesh Kuppuraju4, Peter Daniel Nicholas III5, David Bulbin6, David Pugliese7 and Jonida Cote8, 1Geisinger Medical Center, Danville, PA, 2Geisinger, Danville, PA, 3Geisinger Medical Center, Lewisburg, PA, 4Geisinger Medical Center, General Rheumatology Fellowship, Danville, PA, 5Geisinger Medical Center, Leesport, PA, 6Geisinger Health System, Danville, PA, 7Geisinger Health System, Wilkes-Barre, PA, 8Geisinger Medical Center, Orefield, PA

    Background/Purpose: Physicians strive to provide patient-centered, timely care, often with perceived inadequate blocked time on the schedule. We aim to understand the joint injection workflow,…
  • Abstract Number: 1777 • ACR Convergence 2022

    A Symptom Checker App Is Better at Classifying Inflammatory Disease Than Physicians Who Are Presented Identical Information

    markus Gräf1, Johannes Knitza2, Jan Leipe3, Martin Krusche4, Martin Welcker5, Sebastian Kuhn6, Johanna Mucke7, Axel Hueber8, Johannes Hornig9, Philipp Klemm10, stefan Kleinert11, Peer Aries12, Nicolas Vuillerme13, Arnd Kleyer2, Georg Schett14 and Johanna Callhoff15, 1Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, 2Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, 91054 Erlangen, Germany; Deutsches Zentrum Immuntherapie, Friedrich-Alexander-UniversityErlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, 3Division of Rheumatology, Department of Medicine V, University Hospital Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Heidelberg, Germany, 4University Hospital Hamburg-Eppendorf, Hamburg, Germany, 5GBR, Planegg, Germany, 6Department of Digital Medicine, Medical Faculty OWL, Bielefeld University, Bielefeld, Germany, 7Policlinic and Hiller Research Center, Heinrich-Heine-University Duesseldorf, Neuss, Germany, 8Paracelsus University Nürnberg, Erlangen, Germany, 9Rheumatologische Schwerpunktpraxis, Osnabrück, Germany, 10Campus Kerckhoff of Justus Liebig University Giessen, Bad Nauheim, Germany, 11Praxisgemeinschaft Rheumatologie - Nephrologie (PGRN), Erlangen, Germany, 12Rheumatologie im Struenseehaus, Hamburg, Germany, 13Université Grenoble Alpes, AGEIS, Grenoble, France, 14Universitätsklinikum Erlangen, Erlangen, Germany, 15German Rheumatism Research Centre, Berlin, Germany

    Background/Purpose: The purpose of this study was to compare the ability of an artificial intelligence-based symptom checker app (Ada) and physicians to determine the presence/absence…
  • Abstract Number: 0087 • ACR Convergence 2022

    Does Limited English Proficiency Lead to Additional Health Inequity in Medically Vulnerable Populations in Outpatient Rheumatology?

    Veena Patel1 and Kevin Hackshaw2, 1Dell Medical School - UT Health Austin, Austin, TX, 2The University of Texas at Austin, Hutto, TX

    Background/Purpose: Lack of health insurance and limited English proficiency (LEP) are two factors that can create significant health disparity in the United States which can…
  • Abstract Number: 0629 • ACR Convergence 2022

    The Cellular Metabolism of SLE NK Cells Is Primarily Altered at the Level of Mitochondrial Respiration

    Natalia Fluder, Morgane Humbel, camillo Ribi and Denis Comte, Service of Immunology and Allergy / CHUV, Lausanne, Switzerland

    Background/Purpose: Systemic lupus erythematosus (SLE) is a systemic inflammatory disorder, which involves a loss of tolerance and development of autoantibodies. The role of Natural Killer…
  • Abstract Number: 1286 • ACR Convergence 2022

    Increasing Biosimilar Uptake in the Rheumatology Clinics Within a Large Academic Medical Center

    Joad Eseddi1, DeAnne Carmichael2, Shannon Wishin3 and Puneet Bajaj2, 1UT Southwestern School of Medicine, Dallas, TX, 2UT Southwestern Medical Center, Dallas, TX, 3UT Southwestern Medical Centre, Dallas, TX

    Background/Purpose: Biological drugs have revolutionized the treatment of rheumatic diseases. However, increasing the use of biologics over the past few years has directly contributed towards…
  • Abstract Number: 1926 • ACR Convergence 2022

    Analysis of New Patient Referrals to a Large Pediatric Rheumatology Clinic

    Daniel Reiff, Melissa Mannion, Emily Smitherman, Matthew Stoll, Peter Weiser and Randy Cron, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Large pediatric rheumatology centers receive hundreds of yearly referrals with a wide variety of complaints and diagnoses. The amount of referrals received can lead…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 24
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology